Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
An estimated 21 million American women experience BV
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
No new studies have been requested
It is an application to automate statistical analysis and reporting for clinical research.
A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA
Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Subscribe To Our Newsletter & Stay Updated
